Tracy Lively

9.9k total citations · 1 hit paper
19 papers, 2.1k citations indexed

About

Tracy Lively is a scholar working on Cancer Research, Statistics and Probability and Molecular Biology. According to data from OpenAlex, Tracy Lively has authored 19 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 7 papers in Statistics and Probability and 6 papers in Molecular Biology. Recurrent topics in Tracy Lively's work include Cancer Genomics and Diagnostics (8 papers), Statistical Methods in Clinical Trials (7 papers) and Breast Cancer Treatment Studies (4 papers). Tracy Lively is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Statistical Methods in Clinical Trials (7 papers) and Breast Cancer Treatment Studies (4 papers). Tracy Lively collaborates with scholars based in United States, Canada and United Kingdom. Tracy Lively's co-authors include Lisa M. McShane, Daniel F. Hayes, Torsten O. Nielsen, Mathew J. Ellis, Janine Salter, Seungmok Paik, Christos Sotiriou, Ludmila Prudkin, N. Lynn Henry and Judith Hugh and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Nature Reviews Drug Discovery.

In The Last Decade

Tracy Lively

18 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

2011 1.5k citations Torsten O. Nielsen, Roger A’Hern et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tracy Lively United States	10	1.2k	991	536	411	353	19	2.1k
Lila Zabaglo United Kingdom	16	1.4k 1.1×	1.2k 1.2×	421 0.8×	356 0.9×	399 1.1×	37	1.9k
MM Regan Switzerland	9	1.1k 0.9×	1.0k 1.0×	329 0.6×	377 0.9×	294 0.8×	32	1.7k
Sean Ferree United States	17	1.6k 1.3×	1.1k 1.1×	597 1.1×	294 0.7×	536 1.5×	49	2.1k
J. Zujewski United States	10	1.0k 0.8×	1.1k 1.1×	548 1.0×	388 0.9×	290 0.8×	16	1.9k
Wanseop Kim United States	4	1.5k 1.2×	1.0k 1.0×	462 0.9×	388 0.9×	297 0.8×	6	1.9k
Jeremy Thomas United Kingdom	29	1.2k 1.0×	1.1k 1.1×	579 1.1×	517 1.3×	362 1.0×	90	2.2k
Fanny Piette Belgium	14	1.4k 1.1×	2.0k 2.0×	1.3k 2.4×	228 0.6×	458 1.3×	24	3.4k
Jo Anne Zujewski United States	16	739 0.6×	710 0.7×	317 0.6×	298 0.7×	284 0.8×	29	1.6k
Arno Floore Netherlands	20	1.5k 1.2×	1.3k 1.3×	1.3k 2.5×	471 1.1×	345 1.0×	33	2.8k
Esther H. Lips Netherlands	30	1.2k 1.0×	1.2k 1.2×	1.1k 2.1×	481 1.2×	287 0.8×	84	2.7k

Countries citing papers authored by Tracy Lively

Since Specialization

Citations

This map shows the geographic impact of Tracy Lively's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracy Lively with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracy Lively more than expected).

Fields of papers citing papers by Tracy Lively

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracy Lively. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracy Lively. The network helps show where Tracy Lively may publish in the future.

Co-authorship network of co-authors of Tracy Lively

This figure shows the co-authorship network connecting the top 25 collaborators of Tracy Lively. A scholar is included among the top collaborators of Tracy Lively based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tracy Lively. Tracy Lively is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Sparano, Joseph A., Robert J. Gray, Della Makower, et al.. (2023). Abstract GS1-05: Trial Assigning Individualized Options for Treatment (TAILORx): An Update Including 12-Year Event Rates. Cancer Research. 83(5_Supplement). GS1–5. 4 indexed citations

Sparano, Joseph A., Robert J. Gray, Della Makower, et al.. (2019). Impact of clinical risk category on prognosis and prediction of chemotherapy benefit in early breast cancer (EBC) by age and the 21-gene recurrence score (RS) in TAILORx.. Journal of Clinical Oncology. 37(15_suppl). 503–503. 5 indexed citations

Morfouace, Marie, Stephen M. Hewitt, Roberto Salgado, et al.. (2018). A transatlantic perspective on the integration of immuno-oncology prognostic and predictive biomarkers in innovative clinical trial design. Seminars in Cancer Biology. 52(Pt 2). 158–165. 2 indexed citations

Freedman, Andrew N., Carrie N. Klabunde, Lindsey Enewold, et al.. (2018). Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States. JCO Precision Oncology. 2(2). 1–13. 120 indexed citations

Ossandon, Miguel, Lokesh Agrawal, Eric J. Bernhard, et al.. (2018). Circulating Tumor DNA Assays in Clinical Cancer Research. JNCI Journal of the National Cancer Institute. 110(9). 929–934. 67 indexed citations

Sparano, Joseph A., Robert J. Gray, William C. Wood, et al.. (2018). TAILORx: Phase III trial of chemoendocrine therapy versus endocrine therapy alone in hormone receptor-positive, HER2-negative, node-negative breast cancer and an intermediate prognosis 21-gene recurrence score.. Journal of Clinical Oncology. 36(18_suppl). LBA1–LBA1. 8 indexed citations

Freedman, Andrew N., Carrie N. Klabunde, Lindsey Enewold, et al.. (2018). Use of next-generation sequencing tests to guide cancer treatment: Results from a survey of U.S. oncologists.. Journal of Clinical Oncology. 36(15_suppl). 6529–6529.

Yee, Laura M., Tracy Lively, & Lisa M. McShane. (2018). Biomarkers in Early-Phase Trials: Fundamental Issues. Bioanalysis. 10(12). 933–944. 24 indexed citations

Salgado, Roberto, Helen M. Moore, John W.M. Martens, et al.. (2017). Steps forward for cancer precision medicine. Nature Reviews Drug Discovery. 17(1). 1–2. 23 indexed citations

10.

Lively, Tracy, Michael C. Sachs, & Barbara A. Conley. (2015). Translating Promising Biomarkers into Oncology Clinical Practice. 11(1). 14–14. 1 indexed citations

11.

Hall, Jacqueline A., Roberto Salgado, Tracy Lively, Fred C.G.J. Sweep, & Anna Schuh. (2014). A risk-management approach for effective integration of biomarkers in clinical trials: perspectives of an NCI, NCRI, and EORTC working group. The Lancet Oncology. 15(4). e184–e193. 22 indexed citations

12.

McShane, Lisa M., Margaret M. Cavenagh, Tracy Lively, et al.. (2013). Criteria for the use of omics-based predictors in clinical trials. Nature. 502(7471). 317–320. 164 indexed citations

13.

McShane, Lisa M., Margaret M. Cavenagh, Tracy Lively, et al.. (2013). Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration. BMC Medicine. 11(1). 220–220. 85 indexed citations

14.

Taube, Sheila E. & Tracy Lively. (2012). Challenges in Drug and Biomarker Co-Development. Recent results in cancer research. 195. 229–239. 2 indexed citations

15.

Conley, Barbara A., Margaret M. Cavenagh, Tracy Lively, et al.. (2012). Criteria for use of omics-based predictors in NCI-sponsored clinical trials.. Journal of Clinical Oncology. 30(30_suppl). 58–58. 4 indexed citations

16.

Lively, Tracy, et al.. (2012). Bridging the Gap: Moving Predictive and Prognostic Assays from Research to Clinical Use. Clinical Cancer Research. 18(6). 1531–1539. 32 indexed citations

17.

Nielsen, Torsten O., Roger A’Hern, R. Charles Coombes, et al.. (2011). Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group. JNCI Journal of the National Cancer Institute. 103(22). 1656–1664. 1488 indexed citations breakdown →

18.

Taube, Sheila E., James W. Jacobson, & Tracy Lively. (2005). Cancer Diagnostics. PubMed. 5(6). 357–364. 19 indexed citations

19.

Lively, Tracy, et al.. (1999). The emergence of a culture that promotes evidence based clinical decision making within an acute care setting.. PubMed. 11(2). 36–58. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact